Mechanism and Function of a Newly Identified CpG DNA Motif in Human Primary B Cells

Cited by (605)

Items 501–600 of 605

1. Immunostimulatory Activity of Specific CpG Oligonucleotides from Bifidobacterium longum Genome on RAW 264.7 Macrophage Cells
   Jeong Min Seo · 2009 · Journal of the Korean Society for Applied Biological Chemistry
2. INDUCTION OF A PROTECTIVE IMMUNE RESPONSE AGAINST CHLAMYDOPHILA PSITTACI IN SPF CHICKEN FOLLOWING VACCINATION WITH OMP-1 DNA AND CPG OLIGONUCLEOTIDES AS AN ADJUVANT
   Cheng He, Shaowen Li, Yang Li, Guimei He, Wei Yong Liu, Bao-An Yao · 2007
3. Immune Stimulatory Oligonucleotides
   Eugen Uhlmann · 2008 · Royal Society of Chemistry eBooks
4. The Design and Structure–Functional Properties of DNA-Based Immunomodulatory Sequences
   Nikolai V. Kuznetsov · 2013 · Methods in molecular biology
5. In Vitro Effects of Adjuvants on B Cells
   Jörg Vollmer, Hanna Bellert · 2009 · Methods in molecular biology
6. Immunotherapy against Peritoneal Dissemination by Immunostimulatory CpG DNA
   Yukari Kuramoto, Mitsuru Hashida · 2007 · YAKUGAKU ZASSHI
7. CpG ODNs: Precision Immunotherapy and Recent Trends in Nano-Enabled Nucleotide Delivery
   Anamika Verma, Nitisha Beniwal, Chandra Lekha Putta, Sasvat Sayee Ram Ramesh, Sajmina Khatun, Soumitra Pathak, Tomohiko Yamazaki, Aravind Kumar Rengan · 2025 · Critical Reviews in Therapeutic Drug Carrier Systems
8. Turning VDR Off to Turn Immunity On: Metadichol Derepresses VDBP in Human Monocytes
   P R Raghavan · 2026 · Medical Research Archives
9. Application toward Drug Delivery System Using ^|^beta;-1,3-Glucan
   Yoshiya Maegawa, Shinichi Mochizuki, Noriko Miyamoto, Y. Sanada, Kazuo Sakurai · 2015 · Trends in Glycoscience and Glycotechnology
10. Modulation of the Humoral Response to Dermatophagoides pteronyssinus Allergens in BALB/c Mice by Extract Modification and Adjuvant Use
    Yago Pico de Coaña, Jerónimo Carnés, Maria T. Gallego, Carlos Alonso, Nuria Parody · 2011 · International Archives of Allergy and Immunology
11. Potential Immunological Adjuvant of 'K'-Type CpG-Oligodeoxynucleotides Enhanced the Cell Proliferation and IL-6 mRNA Transcription in Canine B Cells
    Shinpei Kawarai, Kaoru Sato, Anna Horiguchi, Keigo Kurata, Akio Kiuchi, Hajime Tsujimoto, Masahiro Sakaguchi · 2010 · Journal of Veterinary Medical Science
12. Phosphorothioate Backbone Modification Changes the Pattern of Responses to CpG
    Katryn J. Stacey, David P. Sester, Shalin H. Naik, Tara Laurine Roberts, Matthew J. Sweet, David Arthur Hume · 2002 · Humana Press eBooks
13. Efficient induction of cross-presentating human B cell by transduction with human adenovirus type 7 vector
    Ying Peng, Meimei Lai, Yun-Yan Lou, Yanqing Liu, Huiyan Wang, Xiaoqun Zheng · 2015 · Immunology Letters
14. Plasmids – vectors for gene therapy
    Piotr Zaleski, Paweł Wawrzyniak, Agnieszka Sobolewska, Grażyna Płucienniczak · 2017 · Postępy Mikrobiologii - Advancements of Microbiology
15. Overrepresentation of immunostimulatory CpG motifs in Burkholderia genomes
    Tom Coenye, Peter A. R. Vandamme · 2005 · Journal of Cystic Fibrosis
16. The importance of the F4 receptor in post-weaned pigs In eliciting F4 specific immune responses in the intestine
    Michael Steven Danabassis · 2006 · University Library - University of Saskatchewan (University of Saskatchewan)
17. Nucleic Acids as Adjuvants
    Kevin Edward Brown, Montserrat Puig, Lydia Asrat Haile, Derek D.C. Ireland, John Martucci, Daniela I. Verthelyi · 2018 · Wiley eBooks
18. Combination mRNA Vaccine Adjuvanted with CpG Oligodeoxynucleotides Enhances Protection against Respiratory Virus Infection
    Lingyan Cui, Sibo Zhang, Yarong Zeng, Limin Zhang, Min Lin, Minqing Hong, Huiqing Chen, Hong Wang, Wenhui Xue, Miaolin Lan et al. · 2026 · ACS Nano
19. Development of Circular CpG Oligodeoxynucleotides for Prolonged Immunostimulation and Synergistic Antitumor Chemotherapy in Melanoma
    Yuqiang Hu, Di Feng, Yizhi Man, Gubu Amu, Nannan Jing, Jing Wang, Qian Wang, Xinjing Tang · 2026 · Journal of Medicinal Chemistry
20. Activation of B cells by CpG Motifs in Bacterial DNA
    Ae‐Kyung Yi, Arthur Μ. Krieg · 2002 · Humana Press eBooks
21. Immortalized B cells: a neverending source of antigen-presenting cells for vaccines?
    Andreas Draube, Michael von Bergwelt‐Baildon · 2008 · Expert Review of Vaccines
22. Toll-like receptor 9 ligand D-type oligodeoxynucleotide D35 as a broad inhibitor for influenza A virus replication that is associated with suppression of neuraminidase activity
    Hiroshi Yamada, Satoshi Nagase, Kazuo Takahashi, Yoshihiro Sakoda, Hiroshi Kida, Shigefumi Okamoto · 2016 · Antiviral Research
23. Structure/Function of IFNalpha-Inducing CpG ODNs
    Montserrat Puig, Daniela I. Verthelyi · 2008 · CRC Press eBooks
24. Vaccine Adjuvants
    Dennis M. Klinman, Hidekazu Shirota · 2017 · Wiley-VCH eBooks
25. Nano-Adjuvants
    Bishal Misra, Krystal A. Hughes, Sharan Kumar Reddy Bobbala · 2023 · AAPS advances in the pharmaceutical sciences series
26. Evaluation of NFKB1 and MyD88 expression levels in a sample of non-Hodgkin lymphoma patients before and during chemotherapy
    Eman Rashwan, Nagi Ali Ibrahim, Mohamed Labib Salem · 2024 · Egyptian Journal of Basic and Applied Sciences
27. Toll‐like receptors in the functional orientation of cardiac progenitor cells
    Mohammadreza Yousefi, Mina Mamipour, Sadiye E. Sokullu, Shahrooz Ghaderi, Hassan Amini, Reza Rahbarghazi‬ · 2019 · Journal of Cellular Physiology
28. Novel Adjuvants
    Burcu Temizoz, Etsushi Kuroda, Kouji Kobiyama, Taiki Aoshi, Ken J. Ishii · 2016 · Springer eBooks
29. Host and Pathogen Sensory Systems as Targets for Therapeutic Intervention
    K. Jason Kindrachuk · 2008 · University Library - University of Saskatchewan (University of Saskatchewan)
30. Nucleic Acid‐Based Therapies
    Britta Höhn, John J. Rossi · 2010
31. Impact of Site-Specific Nucleobase Deletions on the Arthritogenicity of DNA
    Jan L. Bjersing, Andrej Tarkowski, Ekambar R. Kandimalla, Helén Karlsson, Sudhir Agrawal, L. Vincent Collins · 2004 · Inflammation
32. Antisense therapy
    Stanley T. Crooke · 2003 · Elsevier eBooks
33. "A viper and engine of the devil": The violent woman and female/female violence in eighteenth-century fiction
    Wendy J Wenner · 1993 · e-Publications@Marquette (Marquette University)
34. Mechanisms of TLR signaling and cooperation in B lymphocytes
    Claire M. Buchta · 2014
35. Co-evolutionary analysis suggests a role for TLR9 in papillomavirus restriction
    Kelly M. King, Brendan B. Larsen, Sophie Gryseels, Cécile Richet, Simona J. Kraberger, Robert Jackson, Michael Worobey, Joseph S. Harrison, Arvind Varsani, Koenraad Van Doorslaer · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
36. Animal Vaccine Technology: A Review
    Li-Ting Cheng, Yao-Chi Chung, Chung‐Da Yang, Kuo‐Pin Chuang, Guan‐Ming Ke, Chun-Yen Chu · 2014 · Springer eBooks
37. DNA Damage Response Suppresses Epstein-Barr Virus-Driven Proliferation of Primary Human B Cells
    Pavel A. Nikitin · 2012 · DukeSpace (Duke University)
38. Targeted Downregulation of TGF-β2 with AP 12009 in Tumor Therapy
    Karl‐Hermann Schlingensiepen, Piotr Jachimczak, Birgit Fischer-Blass, Dagmar Fischer, Heike Specht, S. Schmaus, Reimar Schlingensiepen · 2008 · Humana Press eBooks
39. Immunotoxicity: technologies for predicting immune stimulation, a focus on nucleic acids and haptens
    Jörg Vollmer · 2010 · Cambridge University Press eBooks
40. Modulation and Regulation of Gene Expression by CpG Oligonucleotides
    Dennis M. Klinman, Sven Klaschik · 2010 · Nucleic acids and molecular biology
41. Vergleichende Analyse der anti-Bcl-2 Antisense-Oligonukleotide SPC2996 und Oblimersen in präklinischen Modellen der chronischen lymphatischen Leukämie
    Carola Gigel · 2013 · DuEPublico (University of Duisburg-Essen)
42. The Use of RNA and CpG DNA as Nucleic Acid‐Based Therapeutics
    Jörg Vollmer · 2010
43. Human cytomegalovirus and dendritic cell interaction : Role in immunosupression and autoimmunity
    Stefania Varani · 2005 · Figshare
44. Chapter 12 Primary Biliary Cirrhosis
    Rupert Abdalian, Jenny Heathcote · 2008 · Technical report
45. Use of CpG ODNs in aquaculture: a review.
    María Ángeles Esteban, Alberto Cuesta, José Meseguer, Giacomo Zaccone, Alfonsa Garcı́a Ayala, B. G. Kapoor · 2008
46. Eosinophil as a target for pathophysiological factors and pharmacological compounds
    Pinja Ilmarinen · 2013 · Tampere University Institutional Repository (Tampere University)
47. Development of novel vaccines for the concurrent immunisation against multiple dengue virus serotypes
    Steven C. C. Liew · 2006
48. Immunostimulatory effects of non-CpG oligodeoxynucleotides on cobia (Rachycentron canadum)
    Omkar Vijay Byadgi, Chin-I Chang, Jai‐Wei Lee, Chih‐Chun Jean Huang, Ta‐Chih Cheng · 2015 · Aquaculture International
49. Charakterisierung von dendritischen Zellen nach in vitro Generierung aus konditionierten Medien mithilfe von CpG-Oligonukleotiden oder bakteriellen Extrakten
    Reichert, Mareen · 2010 · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver
50. C6 Immunostimulants in cancer therapy
    James E. Talmadge · 2011 · Birkhäuser Basel eBooks
51. Immuntherapie von Tumoren mit den Pattern-Recognition-Rezeptor-Liganden CpG und poly(I:C) hemmt die Funktion myeloischer Suppressorzellen
    Philipp Max Bittner · 2012 · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München)
52. Recognition of Oligodeoxynucleotides by Toll-like Receptor 9: Phosphodiester Backbone vs. Phosphorothioate Backbone and Monomer vs. Multimer
    Nobutaka Hanagata · 2013 · Nano biomedicine
53. Regulation of TLR9-induced Innate Immune Responses in Sheep Peyer's Patches.
    Jayaum S. Booth · 2009 · University Library - University of Saskatchewan (University of Saskatchewan)
54. Enhancement of HIV-1 DNA immunogens
    Anne Kjerrström Zuber · 2002 · Figshare
55. Toll-like receptor-expressing cells for antiallergy compound screening
    Coline Plé, Catherine Duez · 2008 · Expert Opinion on Drug Discovery
56. Interferon-Induktion durch Triphosphat-RNA
    Jana M. Ellegast · 2010 · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München)
57. INCORPORATION OF CpG OLIGODEOXYNUCLEOTIDES INTO α2-MACROGLOBULIN: DEVELOPMENT OF A NOVEL VACCINE ADJUVANT DELIVERY MECHANISM
    R. B. Anderson · 2007 · DukeSpace (Duke University)
58. This is an author produced version of a paper published in Immunology. This paper has been peer-reviewed but does not include the final publisher proof- corrections or journal pagination.
    Å Månsson, Mikael Adner A, Ulf Höckerfelt · 2006
59. Infection A Proviral Role for CpG in Cytomegalovirus
    Wolfgang Thomas, Chris A. Benedict, Terje Espevik, Siv Helen Moen, Randi Vik, Phil Stephens, Bjørg Steinkjer, Nadra J. Nilsen · 2011
60. Toll-like receptor 9 and systemic autoimmune diseases
    Simon Rothenfußer, Eicke Latz · 2006 · Birkhäuser Basel eBooks
61. Induktion einer potenten antitumoralen Immunantwort durch CpG-aktivierte dendritische Zellen: Vergleich zweier muriner Kolonkarzinom-Modelle.
    Angelika Schlamp · 2005
62. Die Wirkung von 5'Adenosintriphosphat (ATP) auf humane plasmazytoide dendritische Zellen
    Aus der Abteilung, Stefan Endres, Ludwig-Maximilians-Universität München · 2008
63. Die Interaktion der plasmazytoiden dendritischen Zelle mit dem CD8+ T-Lymphozyten
    Ludwig-Maximilians-Universität München · 2014
64. Fremde DNA im menschlichen Genom: Konsequenzen für das Wirts- und das Fremdgenom
    Naturwissenschaftlichen Fakultät · 2013
65. Immunstimulatorische DNA: Wirkung auf Effektorlymphozyten des angeborenen und adaptiven Immunsystems
    Ludwig-Maximilians-Universität München · 2011
66. Unterschiede in IFN- -Produktion und Signaltransduktion der plasmazytoiden dendritischen Zelle nach Stimulation mit CpG-A und CpG-B
    Ludwig-Maximilians-Universität München · 2007
67. A more efficient killing machine : how CpG-oligodeoxynucleotides enhance natural killer cell cytokine production and cytotoxicity against leukemia initiating cells
    Laura Guillon · 2011 · cIRcle (University of British Columbia)
68. Einfluss von Prostaglandin E2 und dem transformierenden Wachstumsfaktor-β auf die plasmazytoide dendritische Zelle
    Ludwig-Maximilians-Universität München · 2007
69. Human milk metagenome: a functional capacity
    Tonya Ward, Sergey Hosid, Ilya P. Ioshikhes, Illimar Altosaar · 2013
70. The future of dentistry: new challenges, new directions.
    J C Sinkford · 1990 · PubMed Central
71. Wirkung auf Effektorlymphozyten des angeborenen und adaptiven Immunsystems.
    Aus der Abteilung, Stefan Endres, Ludwig-Maximilians-Universität München · 2004
72. Aufklärung der Struktur-Wirkungsbeziehungen von CpG-A- und CpG-C-Oligodesoxynukleotiden als Grundlage für die Entwicklung immunstimulatorischer Nanopartikel
    Ludwig-Maximilians-Universität München · 2006
73. CpG-DNA fördert die Bildung von multinukleären Riesenzellen mit Resistenz gegen intrazelluläre Leishmanieninfektion
    Aus der Abteilung, Stefan Endres, Klinikum der Ludwig-Maximilians-Universität München · 2004
74. RNA Interference in Scope of Immune System
    Andrea Ablasser, Gunther Hartmann, Veit Hornung · 2008 · CRC Press eBooks
75. Expression and function of complement- and Toll-like receptors in human B cells under physiological and autoimmune conditions -linking innate and adaptive immunity
    Mariann Kremlitzka, Anna Erdei · 2014
76. inducible gene expression, without significant toxicity - β / α interferon- rituximab in patients with non-Hodgkin lymphoma: increased Combination immunotherapy with a CpG oligonucleotide (1018 ISS) and
    Lee Marshall Nadler, Robert L. Coffman, Arnold S. Freedman, Jonathan W. Friedberg, Helen Kim, Mary McCauley, Edith M. Hessel, Paul W. Sims, David Christopher Fisher · 2013
77. Die plasmazytoide und die myeloide dendritische Zelle: Zusammenhang von Toll-like Rezeptor-Expression und Sensitivität gegenüber Lipopolysaccharid und CpG-DNA
    Martín Reincke, Stefan Endres · 2005
78. Primary Biliary Cholangitisa
    Rupert Abdalian, Jenny Heathcote, Manuel Ramos‐Casals · 2017 · Technical report
79. Short communication Overrepresentation of immunostimulatory CpG motifs in Burkholderia genomes
    Tom Coenye, Peter A. R. Vandamme · 2005
80. Rapid Induction of Protective Immunity Against Biothreat Agents Using CPG-Based Oligonucleotides
    Dennis M. Klinman · 2003
81. Transduction of Bovine Peripheral Blood Mononuclear Cells with Recombinant Bovine Adenovirus-3 Expressing Chimeric pIX
    Bravo Araya, Maria Fragaki · 2018 · HARVEST (University of Saskatchewan)
82. CpG Oligodeoxynucleotides and Their Potential Role in the Immunotherapy of Allergic Diseases
    ARTHUR M. KRIEG · 2002 · Springer eBooks
83. Photoresponsive Gene Delivery System: Photoregulation of Intracellular Trafficking Using Photoresponsive Liposome
    Takeshi Nagasaki, Tsutomu Hamada · 2017 · The Review of Laser Engineering
84. Plasmid basierte DNA-Vektor-Systeme; Aktivierung der angeborenen Immunität durch Modulationen im Vektor-Rückgrat und Einsatz in der Gentherapie
    Denijal Kosovac · 2009 · University of Regensburg Publication Server (University of Regensburg)
85. Immune Adjuvants
    Vassil St. Georgiev · 2009 · Humana Press eBooks
86. Faculty Opinions recommendation of DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activation.
    Facundo D. Batista, Naomi E. Harwood · 2012 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
87. Faculty Opinions recommendation of Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens.
    Ruslan M. Medzhitov · 2001 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
88. Use of CpG ODNs in Aquaculture
    María Ángeles Esteban, Alberto Cuesta, José Meseguer · 2009 · Science Publishers eBooks
89. Immunschwäche
    J. Steinmann, Dieter Kabelitz · 2001 · DMW - Deutsche Medizinische Wochenschrift
90. Targeted barcoding of variable antibody domains and individual transcriptomes of the human B-cell repertoire using Link-Seq
    Hongxing Hu, Fan Zhou, Xiaoli Ma, Karl Albert Brokstad, Leonie Kolmar, Charles Girardot, Vladimı́r Beneš, Rebecca Jane Cox, Christoph A. Merten · 2024 · PNAS Nexus
91. Role of immunostimulatory deoxycytidylate-phosphate-deoxyguanylate (CpG) motifs in oral bacteria associated with oral diseases
    Pisit Charoenwongwatthana, Oslovenya S. Caroline, Halah Ahmed, Jamie Coulter, Chien‐Yi Chang · 2025 · Journal of Oral Microbiology
92. Extremely Low Doses of CpG Oligodeoxynucleotides From Streptococcus thermophilus LacZ Strongly Induce CXCL5 in Macrophages
    Md. Rayhan Chowdhury, Ariful Islam, Takeshi Shimosato · 2025 · Animal Science Journal
93. Residual DNAs as adjuvants in existing mRNA vaccines - a multidisciplinary analysis
    Siguna Mueller · 2025
94. Residual DNAs as adjuvants in existing mRNA vaccines - a multidisciplinary analysis
    Siguna Mueller · 2025
95. Effect of Different Adjuvants on the Immunogenicity of a Recombinant Herpes Zoster Vaccine in Mice, Rats and Non-Human Primates
    Xiaoyang Liu, Shaohua Gong, Jingyi Xu, Ying Wei, Xuyan Chen, Yucheng Wu, Zhengli Zhang, Junyu Ma, Yili Yang, Shuhua Tan · 2025 · Vaccines
96. TOLL-LIKE RECEPTOR 2 EXPRESSION, REGULATION AND SIGNALING
    Nadra J. Nilsen · 2008 · NORA - Norwegian Open Research Archives
97. Additional file 1 of BAX as the mediator of C-MYC sensitizes acute lymphoblastic leukemia to TLR9 agonists
    Bai, Ling, Lei Zhou, Han, Wei, Chen, Jingtao, Gu, Xiaoyi, Hu, Zheng, Yang, Yongguang, Li, Wei, Zhang, Xiaoying, Chao Niu et al. · 2023 · Figshare
98. Modulation of the innate immune response by the oncoviruses EBV and HPV
    Peggy Parroche · 2011 · theses.fr (ABES)
99. Evaluating antiviral activity of nucleic acid binding proteins across species
    Assel Mussabekova · 2019
100. Identification et caractérisation de facteurs impliqués dans la réponse cellulaire aux ARN double brin
     Olivier Petitjean · 2020